State Street’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-16,387
| Closed | -$65.1K | – | 4301 |
|
|
2025
Q3 | $65.1K | Sell |
16,387
-1,297
| -7% | -$8.84K | ﹤0.01% | 4121 |
|
|
2025
Q2 | $212K | Hold |
17,684
| – | – | ﹤0.01% | 3814 |
|
|
2025
Q1 | $243K | Hold |
17,684
| – | – | ﹤0.01% | 3777 |
|
|
2024
Q4 | $252K | Buy |
17,684
+4,006
| +29% | +$65.9K | ﹤0.01% | 3789 |
|
|
2024
Q3 | $261K | Hold |
13,678
| – | – | ﹤0.01% | 3763 |
|
|
2024
Q2 | $267K | Buy |
13,678
+787
| +6% | +$15.2K | ﹤0.01% | 3735 |
|
|
2024
Q1 | $296K | Hold |
12,891
| – | – | ﹤0.01% | 3779 |
|
|
2023
Q4 | $226K | Hold |
12,891
| – | – | ﹤0.01% | 3873 |
|
|
2023
Q3 | $168K | Hold |
12,891
| – | – | ﹤0.01% | 3984 |
|
|
2023
Q2 | $217K | Hold |
12,891
| – | – | ﹤0.01% | 3984 |
|
|
2023
Q1 | $201K | Hold |
12,891
| – | – | ﹤0.01% | 4081 |
|
|
2022
Q4 | $217K | Hold |
12,891
| – | – | ﹤0.01% | 4068 |
|
|
2022
Q3 | $219K | Hold |
12,891
| – | – | ﹤0.01% | 4097 |
|
|
2022
Q2 | $284K | Hold |
12,891
| – | – | ﹤0.01% | 4058 |
|
|
2022
Q1 | $443K | Buy |
12,891
+632
| +5% | +$18.9K | ﹤0.01% | 4102 |
|
|
2021
Q4 | $506K | Hold |
12,259
| – | – | ﹤0.01% | 4019 |
|
|
2021
Q3 | $1.1M | Buy |
12,259
+1,220
| +11% | +$108K | ﹤0.01% | 3759 |
|
|
2021
Q2 | $806K | Buy |
11,039
+8,390
| +317% | +$390K | ﹤0.01% | 3704 |
|
|
2021
Q1 | $98K | Sell |
2,649
-931
| -26% | -$46.7K | ﹤0.01% | 3904 |
|
|
2020
Q4 | $147K | Hold |
3,580
| – | – | ﹤0.01% | 3783 |
|
|
2020
Q3 | $83K | Hold |
3,580
| – | – | ﹤0.01% | 3728 |
|
|
2020
Q2 | $101K | Hold |
3,580
| – | – | ﹤0.01% | 3658 |
|
|
2020
Q1 | $91K | Hold |
3,580
| – | – | ﹤0.01% | 3627 |
|
|
2019
Q4 | $156K | Hold |
3,580
| – | – | ﹤0.01% | 3655 |
|
|
2019
Q3 | $34K | Hold |
3,580
| – | – | ﹤0.01% | 3742 |
|
|
2019
Q2 | $52K | Sell |
3,580
-31,061
| -90% | -$554K | ﹤0.01% | 3718 |
|
|
2019
Q1 | $717K | Buy |
34,641
+4,903
| +16% | +$97.3K | ﹤0.01% | 3398 |
|
|
2018
Q4 | $477K | Sell |
29,738
-1,142
| -4% | -$53.6K | ﹤0.01% | 3453 |
|
|
2018
Q3 | $2.85M | Buy |
30,880
+4,642
| +18% | +$552K | ﹤0.01% | 3118 |
|
|
2018
Q2 | $4.21M | Buy |
26,238
+4,836
| +23% | +$815K | ﹤0.01% | 2948 |
|
|
2018
Q1 | $3.44M | Buy |
21,402
+2,175
| +11% | +$265K | ﹤0.01% | 2954 |
|
|
2017
Q4 | $2.02M | Buy |
19,227
+1,312
| +7% | +$141K | ﹤0.01% | 3178 |
|
|
2017
Q3 | $2.35M | Buy |
17,915
+608
| +4% | +$74.2K | ﹤0.01% | 3132 |
|
|
2017
Q2 | $2.37M | Buy |
17,307
+8,642
| +100% | +$1.04M | ﹤0.01% | 3058 |
|
|
2017
Q1 | $1.03M | Buy |
8,665
+1,846
| +27% | +$218K | ﹤0.01% | 3256 |
|
|
2016
Q4 | $911K | Buy |
6,819
+3,045
| +81% | +$764K | ﹤0.01% | 3298 |
|
|
2016
Q3 | $980K | Buy |
+3,774
| New | +$462K | ﹤0.01% | 3199 |
|
Other funds holding CLSD
State Street's CLSD Position: Q4 2025 in Review
State Street sold out of Clearside Biomedical (CLSD) in Q4 2025, closing a stake of 16,387 shares — an estimated $65.1K sold.
State Street first reported a position in CLSD in Q3 2016 and held it in 37 quarters. The position peaked at $4.21M in Q2 2018. 1 fund tracked by Wall St. Rank holds CLSD as of Q4 2025.
- State Street reported no remaining Clearside Biomedical position as of Q4 2025 after selling out during the quarter.
- State Street sold 16,387 Clearside Biomedical shares in Q4 2025, an estimated $65.1K.
- State Street first reported a position in Clearside Biomedical in Q3 2016 and held it in 37 quarters.
- State Street's Clearside Biomedical position peaked at $4.21M in Q2 2018.
- 1 fund tracked by Wall St. Rank held Clearside Biomedical as of Q4 2025.
Based on State Street's 13F filing for Q4 2025, filed 13 Feb 2026.